Compare MIST & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | SRBK |
|---|---|---|
| Founded | 2003 | 1887 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 123.7M |
| IPO Year | 2019 | 2023 |
| Metric | MIST | SRBK |
|---|---|---|
| Price | $1.38 | $17.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 26.9K |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | N/A | ★ 138.36 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | N/A |
| Revenue This Year | $1,653.36 | N/A |
| Revenue Next Year | $12.32 | N/A |
| P/E Ratio | ★ N/A | $86.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $11.38 |
| 52 Week High | $3.06 | $18.04 |
| Indicator | MIST | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 57.84 |
| Support Level | N/A | $16.27 |
| Resistance Level | $2.01 | $18.04 |
| Average True Range (ATR) | 0.13 | 0.40 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 48.10 | 92.31 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.